Cardiff Oncology Inc Tangible Net Worth Ratio
Cardiff Oncology Inc tangible net worth ratio. Cardiff Oncology Inc (CRDF) has a Tangible Net Worth Ratio of 100.0% as of December 2025. This metric is calculated by deducting intangible assets ($0.00) from net assets ($45.39 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check asset allocation strategy of Cardiff Oncology Inc to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Cardiff Oncology Inc (2012–2025)
Tangible net worth ratio of Cardiff Oncology Inc from 2012 to 2025. This chart shows how Cardiff Oncology Inc's Tangible Net Worth Ratio has changed across 14 annual periods from 2012 to 2025. As of December 2025, the ratio stands at 100.0%, reflecting net assets of $45.39 Million with intangible assets of $0.00 USD. See Cardiff Oncology Inc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Cardiff Oncology Inc Tangible Net Worth Ratio by Year (2012–2025)
Cardiff Oncology Inc tangible net worth ratio by year from 2012 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Cardiff Oncology Inc from 2012 to 2025, covering 14 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see Cardiff Oncology Inc (CRDF) market capitalisation.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 100.0% | $45.39 Million | $0.00 | $61.88 Million | ▲ +0.0 pp |
| 2024 | 100.0% | $82.95 Million | $0.00 | $97.19 Million | ▲ +0.0 pp |
| 2023 | 100.0% | $69.74 Million | $0.00 | $81.64 Million | ▲ +0.0 pp |
| 2022 | 100.0% | $106.34 Million | $0.00 | $116.19 Million | ▲ +0.0 pp |
| 2021 | 100.0% | $140.42 Million | $0.00 | $149.54 Million | ▲ +0.0 pp |
| 2020 | 100.0% | $128.16 Million | $0.00 | $134.73 Million | ▲ +0.0 pp |
| 2019 | 100.0% | $7.31 Million | $0.00 | $13.09 Million | ▲ +0.0 pp |
| 2018 | 100.0% | $10.08 Million | $0.00 | $14.17 Million | ▲ +0.0 pp |
| 2017 | 100.0% | $6.51 Million | $0.00 | $12.29 Million | ▲ +0.0 pp |
| 2016 | 100.0% | $19.77 Million | $0.00 | $43.95 Million | ▲ +0.0 pp |
| 2015 | 100.0% | $48.70 Million | $0.00 | $71.45 Million | ▲ +0.0 pp |
| 2014 | 100.0% | $8.35 Million | $0.00 | $28.90 Million | ▲ +0.0 pp |
| 2013 | 100.0% | $20.39 Million | $0.00 | $27.16 Million | ▲ +0.0 pp |
| 2012 | 100.0% | $2.17 Million | $0.00 | $11.66 Million | — |